Lee, W.C., Balu, S., Cobden, D., Joshi, A.V. and Pashos, C.L. (2006) Medication Adherence and the Associated Health-Economic Impact among Patients with Type 2 Diabetes Mellitus Converting to Insulin Pen Therapy: An Analysis of Third-Party Managed Care Claims Data. Clinical Therapeutics, 28, 1712-1725.
https://doi.org/10.1016/j.clinthera.2006.10.004

has been cited by the following article:

• TITLE: Effect of Initiation of Basal Insulin Glargine on Glycemic Control in Patients with Diabetes: Real Life Experience from Hong Kong

  AUTHORS: Chi-Kin Yeung, Fhkcp Fhkam, Wilson Wai-man Ngai, Ip-tim Lau

  KEYWORDS: Glycemic Control, Insulin Initiation, Insulin Glargine, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Hong Kong

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.7 No.3, July 28, 2017

  ABSTRACT: Introduction: To assess the changes in glycemic control after initiating or switching to a basal insulin analogue in patients with diabetes mellitus. Methods: A retrospective, observational analysis was conducted using electronic data from a Hong Kong regional hospital. Data from adult patients with type 1 and 2 diabetes mellitus (T1DM and T2DM, respectively) who had been prescribed with basal insulin glargine in 2008-2010, with recorded HbA1c levels at the time of initiation, at 6 and 12 months thereafter, were analysed. Results: Data from 106 eligible patients were analysed. Substantial reduction in HbA1c and fasting sugar levels were reported in both T1DM (Δ HbA1c = 1.5%, Δ FBG = 1.3 mmol/L p